DNAprint Genomics (DNAG)

[worktoplay]

Interesting News from PRB Pharmaceuticals:

http://www.prbpharmaceuticals.com/news/attachment/News_BotanicalExtract_072904.pdf

Of course, someone we all know is their CMO and Head of Research and Development:

Hector J. Gomez, M.D., Ph.D., Chief Medical Officer, Head of Research and Development

Dr. Gomez has over twenty years of experience in the biopharmaceutical industry. From 1994-1999, as President and CEO of Transcend Therapeutics, a biotechnology company in Cambridge, MA, Dr. Gomez defined its strategic planning and oversaw its implementation. He led the transition from a private to a public company (IPO). He was also CEO of Zengen, Inc., a private Biotech Company in California. Before joining Transcend, he was Vice President of Medical Affairs for Vertex Pharmaceuticals in Cambridge, MA, where he was responsible for planning and implementing the Pre-Clinical, Clinical Research and Regulatory Affairs departments. Prior to that he was a senior executive for two large pharmaceutical companies: Executive Director, Cardiovascular for Ciba-Geigy in Summit, NJ, and before that, Senior Director, Cardiovascular Clinical Research for Merck in Rahway, NJ. Dr. Gomez received an M.D. from the National University of Colombia, and a Ph.D. from Marquette University and a Diploma in Clinical Pharmacology from Tulane University.

BTW, PRB Pharmaceuticals manufactures Vira 38 in the US.

Later,
W2P